Answers are grounded in this paper and cite their sources.
Alzheimer’s disease (AD) is an intricate neurodegenerative disease. Nucleus Basalis of Meynert (NBM), a key region of the cholinergic system that provides acetylcholine to cortex, has been shown to be target for deep brain stimulation (DBS) in AD. The 5×FAD mouse model was used to investigate the change of behavioral tasks, resting-state functional MRI, and acetylcholinesterase (AChE) assay were applied in this study. We found that NBM-DBS may play an important role in modulating cognitive function and spatial working memory in 5×FAD mice. Increasing functional connectivity and decreasing AChE activity may be the biomarkers for AD individuals.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: